- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02602665
Central Line Placement-EVALUATION OF LINE DEPTH AS A FACTOR IN NEED FOR LINE REPLACEMENT SECONDARY TO MALPOSITION
Central Line Placement Study -EVALUATION OF LINE DEPTH AS A FACTOR IN NEED FOR LINE REPLACEMENT SECONDARY TO MALPOSITION
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Optimal central line placement is vital to catheter longevity. If malpositioned, the catheter may need to get replaced, potentially causing additional morbidity to the patient and additional cost to the healthcare system. In our department, a retrospective study looking at catheter tip position at inital placement and incidence of malposition. In this study, 404 catheter placements were reviewed, and a total of 162 (40.1%) were replaced. Out of the 162 replaced, 36 (22.2%) were replaced secondary to malposition. From this study, we were also able to conclude that catheter tips placed in a deeper position, approximately one and a half vertebral bodies below the carina, were less likely to be malpositioned in the future upon radiographic review.
Current standard of care does not dictate positioning of the line in a specific loacation. In the presence of these findings, we are proposing to conduct a single center randomized control trial in which tunneled central line catheters will be placed in two distinct, select positions. After informed consent is obtained from the patient and family, they will be randomized to one of two treatment groups. The shallow group will have the tip of the catheter located approximately one vertebral body above the carina. The deep group will have the catheter tip placed 1.5 to 2.5 vertebral bodies below the carina. Central line placement will be performed under fluoroscopy in the operating room to optimize catheter placement. Chest X ray in the post operative area will be used to confirm catheter tip position. The catheter tip position will then be followed up prospectively using chest X ray films at or within three months after placement to determine whether there is any malpositioning of the tip.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- The University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children from 0-18 years of age needing a tunneled central line (port or broviac) for treatment of their disease.
Exclusion Criteria:
- Wire exchanged lines
- Non ultrasound placed lines, femoral lines, saphenous vein lines, and cut downs
- Short gut syndrome children < 1 year of age
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Shallow catheter tip placement
Patients randomized to shallow tip placement will have the tip of the catheter placed approximately one vertebral body above to even with the carina.
|
for shallow placement tip of catheter placed 1 vertebral body above to even with the carina
|
|
Experimental: Deep catheter tip placement
Patients randomized to deep tip placement will have the tip of the catheter placed 1.5 to 2.5 vertebral bodies below the carina.
|
deep placement catheter tip is placed 1.5 to 2.5 vertebral bodies below the carina
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Malposition
Time Frame: 90 days
|
The primary outcome measure of this study is to determine whether the position of the tip during central line placement plays a role in malposition during further evaluation of these patients.
This will be determined with chest X-ray done at or within 90 days after line insertion.
All non-ultrasound guided lines and those placed by cut down procedure will be tallied in a prospective manner to calculate the number of lines placed without radiological guidance.
Number of attempts required to place the line (number of times the needle is removed exterior to the skin, i.e. number of skin punctures.)
|
90 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marcus Jarboe, University of Michigan
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 98248
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Access Complication
-
Shanghai Zhongshan HospitalUnknownVascular Access Complication | Vascular Access Site Occlusion | Vascular Access Malfunction
-
Hospital Arnau de VilanovaCompletedVascular Access Complication | Nurse | Vascular Access Devices | NursesSpain
-
Chinese Academy of Medical Sciences, Fuwai HospitalRecruitingVascular Access Complication | Ambulation | Femoral Access Site Closure | Vascular Access Site ManagementChina
-
C. R. BardCompletedVascular Access ComplicationUnited States
-
The University of QueenslandAustralasian Kidney Trials NetworkCompletedVascular Access Complication | Hemodialysis Access Failure (Disorder)Netherlands, Switzerland, Canada, France, United Kingdom, Australia, Malaysia
-
Mayo ClinicCompletedVascular Access ComplicationUnited States
-
Mansoura UniversityUnknownVascular Access ComplicationEgypt
-
Abbott Medical DevicesTerminatedVascular Access ComplicationSpain, Portugal
-
C. R. BardTerminatedVascular Access ComplicationUnited States
-
C. R. BardCompletedVascular Access ComplicationUnited States
Clinical Trials on Shallow catheter tip placement
-
Biotronik SE & Co. KGCompletedAtrial FlutterGermany, Czech Republic, Hungary
-
Tyco Healthcare GroupCompleted
-
Ain Shams UniversityCompletedRadiography | Anatomic Landmarks | Echocardiography, Transesophageal | Catheterization, Central VenousEgypt
-
Neuravi LimitedRecruitingIschemic StrokeGermany, Belgium, Netherlands, France, Ireland
-
Beijing Anzhen HospitalNot yet recruitingTransradial Carotid Artery Stenting | Novel Composite-tip Guiding CatheterChina
-
Zimmer BiometUniversity of Pittsburgh Medical CenterWithdrawnIntracerebral HematomaUnited States
-
Hospital Civil de GuadalajaraActive, not recruitingChronic Kidney Disease (CKD) Stage 5 | Peritoneal Dialysis AccessMexico
-
Herz-Zentrums Bad KrozingenBoston Scientific Corporation; CryoCath Technologies Inc.UnknownAtrial Fibrillation AblationGermany
-
University of AarhusRanders Regional HospitalTerminatedCatheter-Related Infections | Cesarean Section; InfectionDenmark
-
L.V.A. BoersmaCompleted